• HyperScribe™ Poly (A) Tailing Kit Workflow

  2026-08-31

  Build more consistent polyadenylated RNA for transfection experiments, micro-injection, and mechanistic gene-expression studies. The workflow combines a defined E-PAP reaction with RNA quality controls that help distinguish poor transcript performance from biology, including mitochondrial OGDH regulation.

• FXR–KLF11 Signaling in Contrast-Induced Kidney Injury

  2026-08-31

  The reference study identifies an FXR–KLF11 transcriptional axis that suppresses JAK2/STAT3 signaling and reduces contrast-induced acute kidney injury in mouse and HK-2 cell models. Its findings position Chenodeoxycholic Acid (CDCA) as a mechanistic probe for studying nuclear receptor control of renal inflammation and apoptosis, while highlighting the need for further validation before clinical translation.

• BCS Biowaivers for Taltirelin ODTs

  2026-08-30

  Ono and Sugano evaluated whether the BCS biowaiver framework could support bioequivalence assessment of orally disintegrating tablets versus immediate-release formulations for BCS class III drugs. Taltirelin and olopatadine met the required rapid-dissolution criteria, while results from four other drugs showed why dose-to-solubility ratio and formulation-specific dissolution behavior remain important.

• Thioredoxin 1 and Lens Iron Metabolism in Oxidative Damage

  2026-08-29

  This non-peer-reviewed preprint identifies thioredoxin 1 (Trx1) as a potential regulator of late-stage recovery from oxidative damage and iron-homeostasis imbalance in the lens. Its perturbation experiments implicate the iron-storage protein FTH1 downstream of Trx1, providing a testable framework for age-related cataract research while leaving the precise molecular sequence and translational relevance to be validated.

• From Capping to Cancer Immunity

  2026-08-29

  mRNA quality is not a downstream detail: cap orientation, poly(A) design, and transcription consistency can shape the interpretability of translational studies. This thought-leadership guide connects ARCA-capped mRNA production with emerging HCC nanovaccine research and shows where HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) can strengthen an experimental workflow.

• Biotin Azide for Mechanism-Driven Assays

  2026-08-28

  Biotin Azide enables selective capture and detection of alkynylated biomolecules through CuAAC. This article develops a mechanism-driven assay framework inspired by cholesterol–Frizzled5 biology, while clearly separating validated chemistry from exploratory applications.

• LAMP1 and CXCL10–CXCR3 Control Macrophage Polarization

  2026-08-28

  The reference study identifies LAMP1-dependent autophagy as a context-sensitive switch that determines how the CXCL10–CXCR3 axis regulates macrophage polarization. Its combination of pharmacological CXCR3 blockade, LAMP1 knockdown, and a poly(I:C)-induced lung injury model links macrophage signaling to tissue inflammation and provides a framework for interpreting state-dependent CXCR3 antagonist responses.

• MALAT1–miR-135b-5p–GPNMB in Parkinson’s Cells

  2026-08-27

  Lv and colleagues identified a MALAT1/miR-135b-5p/GPNMB regulatory axis that influences proliferation and apoptosis in MPP+-stimulated SK-N-SH and SK-N-BE cells. The study combines lncRNA perturbation, miRNA–target validation, and functional rescue logic, while also illustrating why metabolic and apoptosis readouts should be interpreted together in Parkinson’s disease cell models.

• MCL-1 Dependence in Breast Cancer: Apoptotic Function

  2026-08-27

  The reference study shows that established breast cancer tumors depend on MCL-1 primarily because of its canonical anti-apoptotic activity. By combining acute genetic deletion, pharmacological inhibition, and BAX/BAK dependency testing, the work links MCL-1 targeting to mitochondrial apoptosis and clarifies how selective MCL-1 inhibitors should be interpreted in breast cancer research.

• RB1-Deficient Organoids Reveal Retinoblastoma Origins

  2026-08-26

  A 2026 Cell Death and Disease study uses RB1-deficient human retinal organoids, longitudinal profiling, and single-cell RNA sequencing to distinguish the retinal cells most sensitive to RB1 loss from the earliest cells that initiate retinoblastoma. The work identifies ATOH7+/RXRγ+ nascent cone precursors as the earliest cellular origin while establishing a human organoid platform for studying retinoblastoma development and therapeutic vulnerabilities.

• Panobinostat (LBH589) Workflow for Cancer Assays

  2026-08-26

  Build more informative HDAC-inhibitor experiments by separating growth arrest from cell killing. This Panobinostat workflow combines concentration–time profiling, orthogonal apoptosis readouts, and practical controls for resistant cancer models.

• Purmorphamine Smoothened Agonist Workflows

  2026-08-25

  Purmorphamine provides direct Smoothened activation for osteoblast differentiation, mesenchymal stem cell Hedgehog modulation, and exploratory sensory biology. This workflow-focused guide connects dose design, pathway readouts, bee olfaction findings, and practical troubleshooting without treating cross-species results as interchangeable.

• LC-MS/MS Metabolomics of Carbapenem Resistance

  2026-08-25

  A 2025 study used LC-MS/MS metabolomics and supervised machine learning to distinguish carbapenemase-producing from non-producing Enterobacterales after antibiotic-free growth. Its 21 candidate biomarkers and pathway-level findings support faster resistance phenotyping while highlighting the need for broader validation before clinical implementation.

• Tyrothricin: From Membrane Action to Translation

  2026-08-24

  Tyrothricin offers translational researchers a membrane-focused platform for studying antimicrobial activity across bacterial, fungal, and selected viral models. This thought-leadership article connects its peptide antibiotic mixture profile with rigorous assay design, product handling, competitive positioning, and a carefully bounded analogy to membrane and cell-communication findings in inflammatory pain research.

• EZ Cap™ Human PTEN mRNA (ψUTP) Workflow

  2026-08-23

  Build reproducible PTEN-restoration experiments with a Cap 1, pseudouridine-modified in vitro transcribed mRNA designed for efficient mammalian translation. This workflow connects transient PTEN expression to PI3K/Akt pathway assays, trastuzumab-resistance models, nanoparticle benchmarking, and practical troubleshooting.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page